Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News Twist Bioscience Corporation TWST

Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throu...


Recent & Breaking News (NDAQ:TWST)

Twist Bioscience Expands Gene Product Line with Launch of Clonal-Ready Gene Fragments

Business Wire December 10, 2020

Twist Bioscience Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares

Business Wire December 7, 2020

Twist Bioscience Announces Proposed Public Offering of Common Stock

Business Wire December 1, 2020

Twist Bioscience to Present at Upcoming Virtual Investor Conferences

Business Wire November 24, 2020

Twist Bioscience Reports Fourth Quarter and Full Year Fiscal 2020 Financial Results

Business Wire November 23, 2020

Twist Bioscience Announces Positive Preclinical Data for SARS-CoV-2 Antibodies

Business Wire November 23, 2020

Twist Bioscience and Biotia Announce Research Use Only Availability of First Hybridization Capture-Based Next-Generation Sequencing SARS-CoV-2 Assay for Characterization and Surveillance of the Virus

Business Wire November 19, 2020

Twist Bioscience Ranked 60th Fastest Growing Company in North America on Deloitte's 2020 Fast 500(TM)

Business Wire November 18, 2020

Twist Bioscience Expands Infectious Disease Product Line Adding Comprehensive Viral Panel

Business Wire November 16, 2020

Twist Bioscience Continues Support for Next Generation of Synthetic Biologists Through Work with iGEM Competition

Business Wire November 16, 2020

Twist Bioscience, Illumina and Western Digital Form Alliance with Microsoft to Advance Data Storage in DNA

Business Wire November 12, 2020

Twist Bioscience to Present at the Stifel 2020 Virtual Healthcare Conference

Business Wire November 10, 2020

Twist Bioscience to Report Fiscal 2020 Fourth Quarter and Full Year Financial Results on Monday, November 23, 2020

Business Wire November 2, 2020

Twist Bioscience Showcases Next-Generation Sequencing Presentations at Virtual American Society for Human Genetics 2020 Annual Meeting

Business Wire October 29, 2020

Twist Bioscience Collaborates With Beyond Earth to Launch Artwork Stored in DNA Into Space

Business Wire October 27, 2020

Twist Bioscience to Host Virtual Biopharma Analyst & Investor Event on October 23, 2020

Business Wire October 13, 2020

Twist Bioscience and Neogene Announce Broad Strategic Partnership for Next Generation Personalized T Cell Therapies

Business Wire October 13, 2020

Emily Leproust, Ph.D., to Receive 2020 Rosalind Franklin Award

Business Wire September 18, 2020

Twist Bioscience to Present at Upcoming Virtual Investor Conferences

Business Wire September 3, 2020

Twist Bioscience Announces Potent SARS-CoV-2 Neutralizing Data from COVID-19 Therapeutic Antibody Program

Business Wire September 2, 2020